T. Rowe Price Associates
OMED

T. Rowe Price Associates’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

T. Rowe Price Associates’s Portfolio OMED Stock Details OMED Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
2017
Q1 		$190K Buy
2016
Q4 		$159K Buy
2015
Q1 		– Sell
2014
Q4 		$990K Sell
2014
Q3 		$2.42M Buy
2014
Q2 		$1.21M Buy
2013
Q4 		– Sell
2013
Q3 		$1.07M Buy